Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.

Sprute, Rosanne; Hieber, Marie-Lisa; Jachimowicz, Ron D

Sprute, Rosanne; Hieber, Marie-Lisa; Jachimowicz, Ron D.

Sprute R; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Hieber ML; Cologne Excellence Cluster On Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
Jachimowicz RD; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.

Infection ; 50(6): 1617-1618, 2022 12.

Article in English | MEDLINE | ID: covidwho-2129445

Subject(s)

COVID-19 Vaccines; COVID-19; Lymphohistiocytosis, Hemophagocytic; Humans; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Lymphohistiocytosis, Hemophagocytic/diagnosis; Lymphohistiocytosis, Hemophagocytic/etiology; SARS-CoV-2; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / COVID-19 Vaccines / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-022-01820-z

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google